Abbott has received reports of 73 injuries concerning its Abbott Proclaim and Infinity neurostimulation systems, which deliver low-intensity electrical impulses and are used for chronic pain, the FDA said Sept. 13.
Read the full post on Becker's Hospital Review - Healthcare News
